000 | 01955 a2200553 4500 | ||
---|---|---|---|
005 | 20250517074341.0 | ||
264 | 0 | _c20161010 | |
008 | 201610s 0 0 eng d | ||
022 | _a1479-5876 | ||
024 | 7 |
_a10.1186/s12967-016-0774-3 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRaphael, Roseanne | |
245 | 0 | 0 |
_aCombining patient proteomics and in vitro cardiomyocyte phenotype testing to identify potential mediators of heart failure with preserved ejection fraction. _h[electronic resource] |
260 |
_bJournal of translational medicine _cJan 2016 |
||
300 |
_a18 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAmino Acid Sequence |
650 | 0 | 4 |
_aCalgranulin A _xblood |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHeart Failure _xdiagnostic imaging |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInduced Pluripotent Stem Cells _xcytology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMolecular Sequence Data |
650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
650 | 0 | 4 |
_aPeptides _xchemistry |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 |
_aProteome _xmetabolism |
650 | 0 | 4 |
_aProteomics _xmethods |
650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
650 | 0 | 4 | _aReproducibility of Results |
650 | 0 | 4 |
_aStroke Volume _xdrug effects |
650 | 0 | 4 | _aTandem Mass Spectrometry |
650 | 0 | 4 | _aUltrasonography |
700 | 1 | _aPurushotham, Diana | |
700 | 1 | _aGastonguay, Courtney | |
700 | 1 | _aChesnik, Marla A | |
700 | 1 | _aKwok, Wai-Meng | |
700 | 1 | _aWu, Hsiang-En | |
700 | 1 | _aShah, Sanjiv J | |
700 | 1 | _aMirza, Shama P | |
700 | 1 | _aStrande, Jennifer L | |
773 | 0 |
_tJournal of translational medicine _gvol. 14 _gp. 18 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12967-016-0774-3 _zAvailable from publisher's website |
999 |
_c25652815 _d25652815 |